Doctor Troels Yndigegn

Department of Cardiology, Lund (Sweden)

Membership: ESC Professional Member

Follow

Contributor content

Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

Presentation

Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

ESC 365 is supported by

novartis

Explore sponsored resources